传入的流感基因组组装了一个宿主RBP网络,该网络调节病毒RNA合成
Stephen Clarke1, Deep B Patel1, Andrea Ascura1
1Department of Biochemistry, Vanderbilt University, Nashville, TN 37232, USA.
bioRxiv : the preprint server for biology
|December 19, 2025
概括
流感A病毒 (IAV) RNA在进入时招募了数百种人类蛋白质. 这些宿主因素,包括GMPS,TOP2A,SRRM2和SPEN,对于病毒复制至关重要,并提供新的抗病毒标.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 宿主-病原体相互作用
背景情况:
- 流感A病毒 (IAV) 复制在进入后迅速开始.
- 与病毒基因组相互作用的最早宿主因素在很大程度上是未知的.
研究的目的:
- 在病毒转录之前,识别与传入的IAV基因组相互作用的宿主蛋白质.
- 了解这些早期宿主-病毒RNA相互作用在病毒复制中的作用.
主要方法:
- 利用VIR-CLASP技术捕获蛋白质-RNA与原始病毒RNA (vRNA) 的相互作用.
- 鉴定和表征了约700种与IAV基因组相互作用的人类RNA结合蛋白 (RBPs).
- 对已识别的关键宿主因素进行功能研究.
主要成果:
- 通过传入的IAV负义基因组招募的700个人类RBP.
- 这些RBP参与RNA代谢,染色质重塑和核组织.
- 证实GMPS,TOP2A,SRRM2和SPEN是IAV复制的不同阶段所必需的关键前病毒因素,包括vRNA/cRNA/mRNA生成,mRNA封闭和病毒RNA剪接.
结论:
- 传入的IAVvRNA作为一个支架,组装宿主核机械进行复制.
- 这项研究揭示了IAV在感染早期参与的广泛的宿主因子网络.
- 这些发现揭示了针对IAV的抗病毒策略的新宿主漏洞.
相关概念视频
Viruses with RNA Genomes
730
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
730
Leaky Scanning
5.6K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.6K
Retrovirus Life Cycles
49.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.1K
Size and Structure of Viral Genomes
622
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
622
siRNA - Small Interfering RNAs
18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K
RNA Interference
27.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.7K


